C92.01
Acute myeloblastic leukemia, in remission
Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 3 never code together
C92.0code
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Instructional notes 20
C92code
Includes
- granulocytic leukemia
- myelogenous leukemia
Code also
- , if applicable, pancytopenia (acquired) (D61.818)D61.818
C92.0code
Inclusion terms
- Acute myeloblastic leukemia, minimal differentiation
- Acute myeloblastic leukemia (with maturation)
- Acute myeloblastic leukemia 1/ETO
- Acute myeloblastic leukemia M0
- Acute myeloblastic leukemia M1
- Acute myeloblastic leukemia M2
- Acute myeloblastic leukemia with t(8;21)
- Acute myeloblastic leukemia (without a FAB classification) NOS
- Refractory anemia with excess blasts in transformation [RAEB T]
C00-D49chapter
Notes
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).C25.9
Index entries leading here 2
Alongside this code 2 same parent — C92.0
Medications 5
37 Leukemia, Myeloid, Acute drugs 4 Leukemia, Promyelocytic, Acute drugs 2 Leukemia, Eosinophilic, Acute drugs 2 Leukemia, Basophilic, Acute drugs 1 Leukemia, Myelomonocytic, Acute drugs
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
AHA Coding Clinic® Licence required
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.